This inventor holds 2 USPTO granted patents. Top assignee: Vanderbilt University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jillian P. Rhoads: Neuropsychiatric Disorder Treatment Innovation.
Introduction
Jillian P. Rhoads is an inventor associated with Vanderbilt University in Nashville, Tennessee. Her patent work addresses potential treatment approaches for neuropsychiatric disorders linked to immune responses or genetic variation affecting the NMDA receptor.
Latest Patents
Rhoads is named on 1 patent, titled “Methods of Treating Anti-NMDAR-Associated Neuropsychiatric Disorders.” The disclosure describes administering memantine, or a pharmaceutically acceptable salt of memantine, to treat certain neuropsychiatric disorders. The conditions discussed are associated with GluN2A expression, anti-double-stranded DNA antibodies that cross-react with NMDA receptor subunits, or mutations in the GRIN2A gene.
Career Highlights
Rhoads’s listed patent reflects work at the intersection of neuroscience, immunology, and therapeutic development. It focuses on a treatment strategy for disorders associated with NMDA receptor-related antibodies or genetic mutations.
Collaborations
The provided information identifies Jill M. Pulley as a coworker and Vanderbilt University as Rhoads’s company affiliation. No further details about their specific collaboration are available in the supplied information.
Conclusion
Jillian P. Rhoads’s patent documents a memantine-based approach to treating neuropsychiatric disorders associated with NMDA receptor-related immune or genetic factors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile